Keep REMS Requirements Straight

Drugs with Risk Evaluation and Mitigation Strategies (REMS) are back in the spotlight...due to updates to some of these med safety programs.

The iPLEDGE program for isotretinoin will now allow pharmacies to get a Risk Management Authorization (RMA) through their pharmacy network without having to call or go to the iPLEDGE website.

Plus short-acting opioids will soon have REMS, with FDA considering mandatory pain management training for healthcare providers.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote